Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Twist Bioscience Corp TWST

Healthcare Biotechnology
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of... see more

Recent & Breaking News (NDAQ:TWST)

Twist Bioscience Launches New NGS Solutions, Highlights Customers at 2020 Advances in Genome Biology and Technology Conference

Business Wire February 24, 2020

GenapSys Partners With Twist Bioscience to Bring Next-Generation Sequencing Target Enrichment and Library Preparation to World's Most Accessible Highly Accurate Sequencer

Business Wire February 24, 2020

Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock

Business Wire February 19, 2020

Twist Bioscience Announces Proposed Public Offering of Common Stock

Business Wire February 18, 2020

Twist Bioscience Now ISO 27001:2013 Certified for Information Security Management System

Business Wire February 12, 2020

Twist Bioscience Reports First Quarter Fiscal 2020 Financial Results

Business Wire February 6, 2020

Twist Bioscience Announces Settlement Agreement with Agilent

Business Wire February 6, 2020

Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market

Business Wire January 27, 2020

Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

PR Newswire January 23, 2020

Twist Bioscience to Report Fiscal 2020 First Quarter Financial Results on Thursday, February 6, 2020

Business Wire January 23, 2020

Twist Bioscience Selected as DNA Synthesis Provider for DNA Data Storage Project Under Intelligence Advanced Research Projects Activity (IARPA) Molecular Information Storage (MIST) Program

Business Wire January 15, 2020

Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery

Business Wire January 15, 2020

Twist Bioscience Promotes Patrick Weiss to Chief Operating Officer Setting Stage for Future Growth

Business Wire January 13, 2020

Twist Bioscience to Present at the 38th Annual J.P. Morgan Healthcare Conference

Business Wire January 6, 2020

Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results

Business Wire December 11, 2019

Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration

Business Wire December 11, 2019

Twist Bioscience to Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on Wednesday, December 11, 2019

Business Wire November 20, 2019

Twist Bioscience Promotes Patrick J. Finn, Ph.D., to Chief Commercial Officer

Business Wire November 20, 2019

Twist Bioscience to Present at Upcoming Investor Conferences

Business Wire November 13, 2019

Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery

Business Wire November 8, 2019